Crescita Therapeutics Inc (CTX) — Cash Flow Quality Index
Crescita Therapeutics Inc (CTX) has a Cash Flow Quality Index of 1.56x as of September 2025. Operating cash flow of CA$1.17 Million exceeds net income of CA$753.00K, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Crescita Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Crescita Therapeutics Inc Cash Flow Quality Index (2018–2022)
Historical Cash Flow Quality Index for Crescita Therapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Crescita Therapeutics Inc cash conversion from operations.
Annual Cash Flow Quality Index for Crescita Therapeutics Inc (2018–2022)
Year-by-year earnings quality comparison for Crescita Therapeutics Inc.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.18x | CA$-1.02 Million | CA$862.00K | ▼ -100.8% |
| 2020 | 151.57x | CA$5.61 Million | CA$37.00K | ▲ +5198.9% |
| 2019 | 2.86x | CA$5.31 Million | CA$1.85 Million | ▲ +563.7% |
| 2018 | -0.62x | CA$-1.48 Million | CA$2.40 Million | — |